Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.
-
Role of inactivating ARID1A mutation on the tumor microenvironment in response to immune checkpoint therapy
Hawraa N. Al Janabi, Seanu M. Natarajan, and Sangeeta Goswami
-
Rimiducid Stimulates Differentiation of Thymocytes into Helper T Cells and Inhibits Development of Central Memory Helper T Cells
Brian Dineen, Dan Li, Rolando Vedia, Mao Zhang, and Qing Ma
-
MRI-Based Therapy Guidance for Ultrasound Neuromodulation
Marie Gerges, Wayne Goodman, Junqian Xu, Xuefeng Zhang, Joo-won Kim, and Richard Bouchard
-
Mathematical Modeling of CA19-9 Normalization in Pancreatic Cancer Patients
Lauren V. Hollmer; Connor Thunshelle; Tasadduk H. Chowdhury; and Eugene J. Koay MD, PhD
-
Analysis of Neural Quantification and Phenotype through Immunofluorescence Stain in Oropharyngeal Cancer
Margaret Kurop, Tongxin Xie, Jennifer Covello, Jared Burks, and Moran Amit
-
Polarization of Myeloid Cells By Cancer Associated Fibroblasts
Arthur Liu, Priyamvada Jayaprakash, and Michael Curran
-
Characterizing the Abraxas/BRCA1 Interaction in the Control of DNA Double Strand Breaks
Grace Marie Murphy, Xiao Wu, Shengfeng Xu, and Bin Wang
-
Using Thymoquinone As a Novel Drug Targeting EF2K Activity in Treating Pancreatic Cancer
Chelsea O. Popoola, Bulent Ozpolat, Pinar Atalay, and Rumeysa Ozyurt
-
CRISPR-Cas9-mediated Genome Editing Creates Indel Mutations that Lead to Knockout of the ID3 Gene
Calla Sullivan, Zhanyao Tan, and Michael Green
-
Anti-B7H3 Monoclonal Antibodies Induce Natural Killer Cell and T lymphocyte- Mediated Apoptosis in Triple Negative Breast Cancer
Anudishi Tyagi and Venkata Lokesh Battula PhD
-
Association between Clinical Characteristics and Pathologic Nodal Stage in Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer
Elena Rose Wernecke, Puneet Singh, Isabelle Bedrosian, Constance Albarracin, and Hui Chen
